MedTrace Logo

Therapeutic Touch for Intramuscular Injection Pain

NCT07673757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of therapeutic touch on pain intensity associated with intramuscular injection and to examine the relationship between fear of pain and injection-related pain. Participants are assigned to either a therapeutic touch group or a control group. Pain intensity is assessed using a Visual Analog Scale (VAS), and fear of pain is assessed using the Fear of Pain Questionnaire.

Conditions

  • Therapeutic Adherence and Compliance

Interventions

BEHAVIORAL

Supportive Hand-Holding

This intervention involves supportive hand-holding by the patient's companion during the intramuscular injection. Immediately before the injection, the researcher briefly demonstrated to the companion how the hand should be held and provided simple guidance. During the injection, the companion held the patient's hand with both hands, offering a calm, silent, and emotionally supportive presence. The nurse was responsible only for administering the intramuscular injection and monitoring clinical safety; the nurse did not participate in the intervention itself. After the injection, the patient's pain level was assessed using the VAS scale based on self-report.

Sponsors & Collaborators

  • Kilis 7 Aralik University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-03
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07673757 on ClinicalTrials.gov